This inventor holds 28 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in CRISPR Technology. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
18 out of 8,594 
17 out of 488 
12 out of 3,078 
Years Active: 2017-2026
Areas of Expertise:
Title: The Innovative Contributions of Ian Slaymaker
Introduction
Ian Slaymaker, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology. Holding a remarkable total of 18 patents, Slaymaker's work primarily revolves around the groundbreaking CRISPR technology, which has transformed genetic engineering and molecular biology.
Latest Patents
Ian Slaymaker's latest patents reflect his expertise in CRISPR systems. One notable invention involves CRISPR enzymes and systems that provide methods and compositions for targeting nucleic acids. This invention details non-naturally occurring or engineered DNA-targeting systems that include a novel CRISPR effector protein alongside a targeting nucleic acid component like guide RNA. It encompasses methods for creating and utilizing these systems, along with products derived from them.
Another significant patent pertains to CRISPR enzyme mutations aimed at reducing off-target effects. This innovation discloses mutations or modifications of the CRISPR enzyme, specifically a Cas enzyme such as Cas9. These enhancements lead to improved performance in CRISPR-Cas systems, significantly reducing off-target effects. The patent also includes methods for producing and employing these modified enzymes, as well as the systems and products resulting from their use.
Career Highlights
Throughout his career, Ian Slaymaker has been associated with prestigious institutions, including the Massachusetts Institute of Technology and the Broad Institute, Inc., where he has furthered his research and innovation in CRISPR technology. His work has played a crucial role in advancing genetic engineering techniques.
Collaborations
Collaboration has been a key component of Ian Slaymaker's success. He has worked alongside prominent researchers, including Bernd Zetsche and Feng Zhang, who are renowned for their contributions to CRISPR technology. These partnerships have enabled Slaymaker to enrich his research and produce significant advancements in the field.
Conclusion
Ian Slaymaker's innovative work in CRISPR technology underscores his status as a leading inventor in biotechnology. His patents reflect a commitment to developing cutting-edge solutions to complex problems in molecular biology. As the field continues to evolve, Slaymaker’s contributions will undoubtedly pave the way for future advancements and applications in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile